KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Acquisitions (2017 - 2023)

Exact Sciences (EXAS) has disclosed Acquisitions for 6 consecutive years, with $2.4 million as the latest value for Q4 2023.

  • On a quarterly basis, Acquisitions fell 84.3% to $2.4 million in Q4 2023 year-over-year; TTM through Dec 2024 was $67.8 million, a 2.06% increase, with the full-year FY2023 number at $52.4 million, up 256.89% from a year prior.
  • Acquisitions was $2.4 million for Q4 2023 at Exact Sciences, down from $50.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $973.9 million in Q4 2019 to a low of -$1.5 million in Q2 2020.
  • A 5-year average of $128.9 million and a median of $11.8 million in 2022 define the central range for Acquisitions.
  • Peak YoY movement for Acquisitions: soared 4776.65% in 2021, then crashed 99.05% in 2022.
  • Exact Sciences' Acquisitions stood at $973.9 million in 2019, then plummeted by 100.0% to $4000.0 in 2020, then soared by 2104425.0% to $84.2 million in 2021, then plummeted by 81.74% to $15.4 million in 2022, then plummeted by 84.3% to $2.4 million in 2023.
  • Per Business Quant, the three most recent readings for EXAS's Acquisitions are $2.4 million (Q4 2023), $50.0 million (Q3 2023), and $15.4 million (Q4 2022).